DUOX1 and hepatocellular carcinoma: In the HCC cellline SMMC-7721, 5-aza-2’-deoxycytidine treatment reversed DUOX1 silencing anddecreased cell proliferation and colony formation ability through the inductionof G2/M phase cell cycle arrest (Ling etal., 2014).